Literature DB >> 32419083

The efficacy and safety of microwave ablation versus lobectomy for the treatment of benign thyroid nodules greater than 4 cm.

Peng Dong1, Xiao-Li Wu2, Guo-Qing Sui1, Qiang Luo1, Jia-Rui Du1, Hui Wang3, Deng-Ke Teng4.   

Abstract

PURPOSE: To evaluate the safety and effectiveness of microwave ablation (MWA) versus lobectomy for the treatment of benign thyroid nodules > 4 cm.
METHODS: We retrospectively analyzed the data of 48 patients who underwent MWA and 53 patients who underwent lobectomy to treat benign thyroid nodules > 4 cm. The patients were followed up for 12 months. The volume reduction ratio (VRR) was calculated. The operation time, incision length, hospitalization time, complications, thyroid function, symptoms, and cosmetic improvement were analyzed and compared between the two groups.
RESULTS: During the 12-month follow-up, the mean nodule volume in the MWA group was reduced from 36.1 ± 23.1 to 4.0 ± 4.1 ml, and the mean VRR of the nodules was 90 ± 5% in the MWA group, which was comparable with that in the surgery group. No significant postoperative change in thyroid function was observed in the MWA group. Compared with the surgery group, the incidence of complications and postoperative pain in the MWA group were lower, the operation time, incision length, and hospitalization time in the MWA group were shorter, and satisfaction with the esthetic results in the MWA group was greater.
CONCLUSION: MWA is safe and effective for the treatment of benign thyroid nodules > 4 cm. Moreover, MWA is associated with a faster recovery, fewer complications, better protection of thyroid function, and superior esthetic results relative to thyroid lobectomy.

Entities:  

Keywords:  Benign nodules; Lobectomy; Microwave; Thermal ablation; Thyroid; Ultrasound

Year:  2020        PMID: 32419083     DOI: 10.1007/s12020-020-02338-w

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  18 in total

1.  US-guided percutaneous microwave ablation for the treatment of benign thyroid nodules.

Authors:  Wenjun Wu; Xiaohua Gong; Qi Zhou; Xiong Chen; Xiaojun Chen; Bimin Shi
Journal:  Endocr J       Date:  2017-08-29       Impact factor: 2.349

Review 2.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

3.  Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy.

Authors:  Eun Ju Ha; Jung Hwan Baek; Jeong Hyun Lee; Dong Eun Song; Jae Kyun Kim; Young Kee Shong; Suck Joon Hong
Journal:  Thyroid       Date:  2013-05-28       Impact factor: 6.568

Review 4.  Image-guided chemical and thermal ablations for thyroid disease: Review of efficacy and complications.

Authors:  Iain J Nixon; Peter Angelos; Ashok R Shaha; Alessandra Rinaldo; Michelle D Williams; Alfio Ferlito
Journal:  Head Neck       Date:  2018-04-23       Impact factor: 3.147

5.  Cooled microwave ablation of thyroid nodules: Initial experience.

Authors:  Yücel Korkusuz; Oscar Maximilian Mader; Wolfgang Kromen; Christian Happel; Shadi Ahmad; Daniel Gröner; Mithat Koca; Alexander Mader; Frank Grünwald; Hüdayi Korkusuz
Journal:  Eur J Radiol       Date:  2016-09-28       Impact factor: 3.528

6.  Radiofrequency ablation vs. microwave ablation for patients with benign thyroid nodules: a propensity score matching study.

Authors:  Wen-Wen Yue; Shu-Rong Wang; Feng Lu; Li-Ping Sun; Le-Hang Guo; Yong-Lin Zhang; Xiao-Long Li; Hui-Xiong Xu
Journal:  Endocrine       Date:  2016-11-30       Impact factor: 3.633

7.  The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size.

Authors:  Kelly L McCoy; Noel Jabbour; Jennifer B Ogilvie; N Paul Ohori; Sally E Carty; John H Yim
Journal:  Surgery       Date:  2007-11-05       Impact factor: 3.982

8.  US-guided percutaneous microwave ablation versus open radical nephrectomy for small renal cell carcinoma: intermediate-term results.

Authors:  Jie Yu; Ping Liang; Xiao-ling Yu; Zhi-gang Cheng; Zhi-yu Han; Xu Zhang; Jun Dong; Meng-juan Mu; Xin Li; Xiao-hui Wang
Journal:  Radiology       Date:  2013-11-23       Impact factor: 11.105

9.  Malignant liver tumors: treatment with percutaneous microwave ablation--complications among cohort of 1136 patients.

Authors:  Ping Liang; Yang Wang; XiaoLing Yu; Baowei Dong
Journal:  Radiology       Date:  2009-03-20       Impact factor: 11.105

Review 10.  The Diagnosis and Management of Thyroid Nodules: A Review.

Authors:  Cosimo Durante; Giorgio Grani; Livia Lamartina; Sebastiano Filetti; Susan J Mandel; David S Cooper
Journal:  JAMA       Date:  2018-03-06       Impact factor: 56.272

View more
  8 in total

1.  Ultrasound-guided microwave ablation of benign thyroid nodules: effects on inflammatory factors and thyroid function.

Authors:  Zheng Chen; Xin Guo; Xin Yin; Ke Wang; Sa Zhang; Jiaping Li
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Continuous, Large-Volume Hydrodissection to Protect Delicate Structures around the Thyroid throughout the Radiofrequency Ablation Procedure.

Authors:  Yanping Ma; Tao Wu; Zhicheng Yao; Bowen Zheng; Lei Tan; Ge Tong; Yufan Lian; Jung Hwan Baek; Jie Ren
Journal:  Eur Thyroid J       Date:  2021-10-15

Review 3.  Thermal Ablation for Papillary Thyroid Microcarcinoma: How Far We Have Come?

Authors:  Yu Min; Xing Wang; Hang Chen; Jialin Chen; Ke Xiang; Guobing Yin
Journal:  Cancer Manag Res       Date:  2020-12-24       Impact factor: 3.989

4.  Ablating Aspiration Needle Tract Prior to Microwave Ablation Can Improve Therapeutic Outcomes for Predominantly Cystic Thyroid Nodules.

Authors:  Haizhen Yang; Yanwei Chen; Baoding Chen; Shuangshuang Zhao; Zheng Zhang; Keke Wang; Zheming Chen; Huahui Feng; Maohui An
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-24       Impact factor: 5.555

5.  Long-term outcome of microwave ablation for benign thyroid nodules: Over 48-month follow-up study.

Authors:  Jia-Rui Du; Wen-Hui Li; Cheng-Hai Quan; Hui Wang; Deng-Ke Teng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-01       Impact factor: 6.055

6.  Efficacy and safety of ultrasound-guided microwave ablation versus surgical resection for Bethesda category IV thyroid nodules: A retrospective comparative study.

Authors:  Jingjing Yang; Ya Zhang; Xingjia Li; Yueting Zhao; Xue Han; Guofang Chen; Xiaoqiu Chu; Ruiping Li; Jianhua Wang; Fei Huang; Chao Liu; Shuhang Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-23       Impact factor: 6.055

Review 7.  Thermal Ablation of Benign Thyroid Nodules and Papillary Thyroid Microcarcinoma.

Authors:  Xiao-Wan Bo; Feng Lu; Hui-Xiong Xu; Li-Ping Sun; Kun Zhang
Journal:  Front Oncol       Date:  2020-10-29       Impact factor: 6.244

8.  Ultrasound-Guided Thermal Ablation of Bethesda IV Thyroid Nodules: A Pilot Study.

Authors:  Xinyang Li; Yu Lan; Nan Li; Lin Yan; Jing Xiao; Mingbo Zhang; Yukun Luo
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-24       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.